Le vécu de l’annonce d’un cancer à l’ère du dispositif d’annonce

Rannou, Sandrine; Guirimand, Nicolas; Fraval, Frédéric Tresvaux du; Sahbatou, Y.; Lagrange, J. L.; Benoît, G.; Leplège, Alain; Besson, Caroline

doi:10.1007/s11839-011-0330-6

Cited by 11 publications

(6 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is often the ‘brutality’ of a letter announcing the existence of a serious but indeterminate health risk that is generally criticised by HCPs and indeed in contemporary counselling norms for announcing serious illnesses 19. As the same geneticist goes on to suggest, this disclosure is ‘certainly not easy, either for the person receiving the letter or for the person sending it’.…”

Section: Resultsmentioning

confidence: 99%

Familial disclosure by genetic healthcare professionals: a useful but sparingly used legal provision in France

et al. 2019

View full text Add to dashboard Cite

Familial disclosure of genetic information is an important, long-standing ethical issue that still gives rise to much debate. In France, recent legislation has created an innovative and unprecedented procedure that allows healthcare professionals (HCPs), under certain conditions, to disclose relevant information to relatives of a person carrying a deleterious genetic mutation. This article will analyse how HCPs in two medical genetics clinics have reacted to these new legal provisions and show how their reticence to inform the patients’ relatives on their behalf leads them to use this option sparingly.

show abstract

Section: Resultsmentioning

confidence: 99%

Familial disclosure by genetic healthcare professionals: a useful but sparingly used legal provision in France

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Also, the family history of cancer was important, especially for breast cancer, where there was a genetic risk. The patient who has already gone through the bitter experience of this disease with her mother or sister will expect to go through the same suffering again [ 33 ]. In our study, women with a family history of breast cancer did experience this anxiety, but it was not significantly related to the occurrence of depressive disorders.…”

Section: Discussionmentioning

confidence: 99%

Depression and Breast Cancer in Morocco: Prevalence and Associated Factors

Benallel,

El Kilali,

Benjelloun

et al. 2023

International Journal of Breast Cancer

View full text Add to dashboard Cite

Background. Depression is frequently associated with breast cancer. However, its prevalence and impact on patients’ quality of life are negligible. Depression is often underdiagnosed and less treated. Objectives. Our study is aimed at estimating the prevalence of depression in breast cancer patients, describing their sociodemographic and clinical profile, and determining the factors associated with this depression. Material and Methods. We carried out a cross-sectional, descriptive, and analytical study, conducted from January to March 2018 at Mohammed V Military Hospital in Rabat. The survey included 100 breast cancer patients. It was conducted using an anonymous questionnaire, the Mini International Neuropsychiatric Interview test (MINI test) to diagnose depression and the Beck Depression Inventory (BDI) to assess its severity. Results. The major depressive episode was diagnosed in 26% of breast cancer patients. Age under 40, psychiatric history, metastatic breast cancer, refusal of treatment, heavier treatment, and spousal alteration were the factors most associated with higher depression prevalence in these patients. Discussion and Conclusion. The high prevalence of depression in breast cancer patients, as well as the influence of personal characteristics and treatment in the occurrence of this ailment, has been confirmed by several authors. It is recommended to improve the psychooncological care of patients with breast cancer, to prevent the occurrence of depression in this vulnerable population.

show abstract

“…Receiving a diagnosis of PC was a significant milestone for the men. Even though it is the practice in France for nurses to be involved when patients are told of their diagnosis (Rannou et al, 2012), no participant mentioned it, not even the verifiers. The men referred to their encounters with physicians and, less often, with radiation-therapy technicians, psychologists, and physiotherapists.…”

Section: Verifying Our Interpretation Of Findingsmentioning

confidence: 99%

An exploration of Francophone and Francophile men’s representation of prostate cancer: An ethnographic study

Zanchetta¹,

Cognet

Desgrandchamps

et al. 2022

Int Health Trends & Persp

View full text Add to dashboard Cite

Background. Worldwide, men’s health and wellness promotion employ various models and conceptions of masculinity. Masculinities are subjectively experienced and influenced by social differences such as race, class, and sexual orientation. Largely because it threatens men’s gender identity and sexuality, prostate cancer is a prominent and sensitive health issue. How men think, speak about, and represent prostate cancer is affected by their cultural, social, moral, and religious values and beliefs. Methods. Based on data from a larger ethnographic study, this article reports on Francophone and Francophile immigrant men’s experiences and representations of prostate cancer. Data were collected from interviews with 19 men in the cities of Gonesse and Paris, France, using a tool inspired by (core) social representation theory, and submitted to content analysis. Results. Similar views between the two groups of men suggest that the representation of prostate cancer prevalent in French society held more sway over the men’s attitudes and thoughts than any alternative cultural views from the immigrants’ particular ethnic backgrounds. Conclusions. The confirmed view of prostate cancer as a disease with neither a positive nor a negative meaning offered opportunities for the men to re-evaluate their lives and plan their future with realistic expectations.

show abstract

Le vécu de l’annonce d’un cancer à l’ère du dispositif d’annonce

Cited by 11 publications

References 3 publications

Familial disclosure by genetic healthcare professionals: a useful but sparingly used legal provision in France

Familial disclosure by genetic healthcare professionals: a useful but sparingly used legal provision in France

Depression and Breast Cancer in Morocco: Prevalence and Associated Factors

An exploration of Francophone and Francophile men’s representation of prostate cancer: An ethnographic study

Contact Info

Product

Resources

About